A detailed history of Millrace Asset Group, Inc. transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Millrace Asset Group, Inc. holds 46,304 shares of TNDM stock, worth $1.66 Million. This represents 1.99% of its overall portfolio holdings.

Number of Shares
46,304
Holding current value
$1.66 Million
% of portfolio
1.99%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$35.21 - $47.3 $1.63 Million - $2.19 Million
46,304 New
46,304 $1.96 Million
Q3 2023

Nov 13, 2023

BUY
$19.33 - $36.22 $1.06 Million - $1.98 Million
54,706 New
54,706 $1.14 Million
Q1 2023

May 11, 2023

SELL
$35.86 - $46.5 $410,381 - $532,146
-11,444 Reduced 20.36%
44,767 $1.82 Million
Q4 2022

Feb 13, 2023

BUY
$35.49 - $56.15 $1.99 Million - $3.16 Million
56,211 New
56,211 $2.53 Million
Q4 2020

Feb 11, 2021

SELL
$86.4 - $121.75 $643,507 - $906,794
-7,448 Closed
0 $0
Q3 2020

Nov 17, 2020

SELL
$95.43 - $116.09 $826,328 - $1.01 Million
-8,659 Reduced 53.76%
7,448 $845,000
Q2 2020

Aug 13, 2020

BUY
$60.05 - $98.92 $967,225 - $1.59 Million
16,107 New
16,107 $1.59 Million
Q1 2019

May 14, 2019

SELL
$32.25 - $73.56 $1.76 Million - $4.02 Million
-54,590 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$28.45 - $40.65 $11,664 - $16,666
-410 Reduced 0.75%
54,590 $2.07 Million
Q3 2018

Nov 13, 2018

SELL
$21.39 - $51.17 $2.25 Million - $5.37 Million
-105,000 Reduced 65.63%
55,000 $2.36 Million
Q2 2018

Aug 14, 2018

SELL
$4.9 - $23.64 $1.67 Million - $8.04 Million
-340,000 Reduced 68.0%
160,000 $3.52 Million
Q1 2018

May 15, 2018

BUY
$2.35 - $4.96 $1.18 Million - $2.48 Million
500,000 New
500,000 $2.48 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.31B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Millrace Asset Group, Inc. Portfolio

Follow Millrace Asset Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millrace Asset Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Millrace Asset Group, Inc. with notifications on news.